Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell–Mediated Reactions
- 9 March 2024
- journal article
- review article
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 24 (4) , 199-209
Abstract
Purpose of Review To provide an overview on the current understanding of genetic variability in human tryptases and summarize the literature demonstrating the differential impact of mature tryptases on mast cell–mediated reactions and associated clinical phenotypes. Recent Findings It is becoming increasingly recognized that tryptase gene composition, and in particular the common genetic trait hereditary alpha-tryptasemia (HαT), impacts clinical allergy. HαT has consistently been associated with clonal mast cell disorders (MCD) and has also been associated with more frequent anaphylaxis among these patients, and patients in whom no allergic trigger can be found, specifically idiopathic anaphylaxis. Additionally, more severe anaphylaxis among Hymenoptera venom allergy patients has been linked to HαT in both retrospective and prospective studies. An increased relative number of α-tryptase-encoding gene copies, even in the absence of HαT, has also been associated with systemic mastocytosis and has been shown to positively correlate with the severity of mast cell–mediated reactions to vibration and food. These findings may be due to increased generation of α/β-tryptase heterotetramers and differences in their enzymatic activity relative to β-tryptase homotetramers. Summary HαT is a naturally occurring overexpression model of α-tryptase in humans. Increased relative α-tryptase expression modifies immediate hypersensitivity symptoms and is associated with more frequent and severe mast cell–mediated reactions, ostensibly due to increased α/β-tryptase heterotetramer production.Keywords
This publication has 88 references indexed in Scilit:
- Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxisBlood, 2007
- Tryptase haplotype in mastocytosis: Relationship to disease variant and diagnostic utility of total tryptase levelsClinical Immunology, 2007
- Basal serum tryptase level correlates with severity of hymenoptera sting and age.2007
- Tryptase Precursors Are Preferentially and Spontaneously Released, Whereas Mature Tryptase Is Retained by HMC-1 Cells, Mono-Mac-6 Cells, and Human Skin-Derived Mast CellsThe Journal of Immunology, 2003
- The Crystal Structure of Human α1-Tryptase Reveals a Blocked Substrate-binding RegionJournal of Molecular Biology, 2002
- Usefulness of UniCAP‐Tryptase fluoroimmunoassay in the diagnosis of anaphylaxisAllergy, 1999
- Enhancement of vascular permeability by specific activation of protease‐activated receptor‐1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxideBritish Journal of Pharmacology, 1999
- Human β-tryptase is a ring-like tetramer with active sites facing a central poreNature, 1998
- The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.Journal of Clinical Investigation, 1995
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisNew England Journal of Medicine, 1987